Literature DB >> 25405799

Apoferritin applications in nanomedicine.

Zbynek Heger1, Sylvie Skalickova, Ondrej Zitka, Vojtech Adam, Rene Kizek.   

Abstract

Nanomedicine as a continuously evolving discipline is still looking for a structure with perfect properties that is usable as a multifunctional transporter. Great potential is attributed to synthetic materials such as fullerenes, porous hollow silica nanoparticles and single-wall nanotubes, among others. However, materials that are natural to the human body are more acceptable by the organism, and thus become an attractive approach in this field of research. Ferritins are proteins that naturally occur in most living organisms throughout evolution and may be a possible transporter choice. Numerous applications have demonstrated the possibilities of iron-free ferritins, called apoferritins, serving as platforms for various nanomedical purposes This article summarizes the advantages and disadvantages of these proteins and discusses their practical applications and future perspectives.

Entities:  

Keywords:  horse spleen ferritin; magnetic resonance imaging; nanoscale; nanotrasporter; photodynamic therapy; self-assembly; therapeutic agents

Mesh:

Substances:

Year:  2014        PMID: 25405799     DOI: 10.2217/nnm.14.119

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN: 1743-5889            Impact factor:   5.307


  9 in total

Review 1.  In search of effective therapies to overcome resistance to Temozolomide in brain tumours.

Authors:  Kaouthar Bouzinab; Helen Summers; Jihong Zhang; Malcolm F G Stevens; Christopher J Moody; Lyudmila Turyanska; Neil R Thomas; Pavel Gershkovich; Marianne B Ashford; Emily Vitterso; Lisa C D Storer; Richard Grundy; Tracey D Bradshaw
Journal:  Cancer Drug Resist       Date:  2019-12-19

2.  Electrostatic and Structural Bases of Fe2+ Translocation through Ferritin Channels.

Authors:  Balasubramanian Chandramouli; Caterina Bernacchioni; Danilo Di Maio; Paola Turano; Giuseppe Brancato
Journal:  J Biol Chem       Date:  2016-10-18       Impact factor: 5.157

3.  X-ray Structure of the Carboplatin-Loaded Apo-Ferritin Nanocage.

Authors:  Nicola Pontillo; Giarita Ferraro; John R Helliwell; Angela Amoresano; Antonello Merlino
Journal:  ACS Med Chem Lett       Date:  2017-02-28       Impact factor: 4.345

4.  Passive Diffusion vs Active pH-Dependent Encapsulation of Tyrosine Kinase Inhibitors Vandetanib and Lenvatinib into Folate-Targeted Ferritin Delivery System.

Authors:  Zuzana Skubalova; Simona Rex; Martina Sukupova; Martin Zahalka; Petr Skladal; Jan Pribyl; Hana Michalkova; Akila Weerasekera; Vojtech Adam; Zbynek Heger
Journal:  Int J Nanomedicine       Date:  2021-01-06

5.  Therapeutic Efficacy of the Novel Stimuli-Sensitive Nano-Ferritins Containing Doxorubicin in a Head and Neck Cancer Model.

Authors:  Verena Damiani; Elisabetta Falvo; Giulio Fracasso; Luca Federici; Martina Pitea; Vincenzo De Laurenzi; Gianluca Sala; Pierpaolo Ceci
Journal:  Int J Mol Sci       Date:  2017-07-18       Impact factor: 5.923

6.  Identification of Human Enzymes Oxidizing the Anti-Thyroid-Cancer Drug Vandetanib and Explanation of the High Efficiency of Cytochrome P450 3A4 in its Oxidation.

Authors:  Radek Indra; Petr Pompach; Václav Martínek; Paulína Takácsová; Katarína Vavrová; Zbyněk Heger; Vojtěch Adam; Tomáš Eckschlager; Kateřina Kopečková; Volker Manfred Arlt; Marie Stiborová
Journal:  Int J Mol Sci       Date:  2019-07-10       Impact factor: 5.923

7.  Apoferritin/Vandetanib Association Is Long-Term Stable But Does Not Improve Pharmacological Properties of Vandetanib.

Authors:  Kateřina Jáklová; Tereza Feglarová; Simona Rex; Zbyněk Heger; Tomáš Eckschlager; Jan Hraběta; Petr Hodek; Matúš Kolárik; Radek Indra
Journal:  Int J Mol Sci       Date:  2021-04-20       Impact factor: 5.923

8.  Prostate-Specific Membrane Antigen-Targeted Site-Directed Antibody-Conjugated Apoferritin Nanovehicle Favorably Influences In Vivo Side Effects of Doxorubicin.

Authors:  Simona Dostalova; Hana Polanska; Marketa Svobodova; Jan Balvan; Olga Krystofova; Yazan Haddad; Sona Krizkova; Michal Masarik; Tomas Eckschlager; Marie Stiborova; Zbynek Heger; Vojtech Adam
Journal:  Sci Rep       Date:  2018-06-11       Impact factor: 4.379

9.  Questions about horse spleen ferritin crossing the blood brain barrier via mouse transferrin receptor 1.

Authors:  Kelong Fan; Meng Zhou; Xiyun Yan
Journal:  Protein Cell       Date:  2017-11       Impact factor: 14.870

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.